Bruker Co. (NASDAQ:BRKR – Get Free Report) announced a quarterly dividend on Monday, August 12th, Wall Street Journal reports. Shareholders of record on Monday, September 2nd will be given a dividend of 0.05 per share by the medical research company on Monday, September 16th. This represents a $0.20 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date is Friday, August 30th.
Bruker has raised its dividend payment by an average of 7.7% annually over the last three years. Bruker has a payout ratio of 6.6% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Bruker to earn $3.14 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 6.4%.
Bruker Trading Down 0.2 %
BRKR traded down $0.11 during trading on Wednesday, reaching $61.26. 245,926 shares of the company’s stock were exchanged, compared to its average volume of 1,026,318. Bruker has a one year low of $53.79 and a one year high of $94.86. The company has a current ratio of 1.81, a quick ratio of 0.91 and a debt-to-equity ratio of 0.95. The stock has a market capitalization of $8.90 billion, a PE ratio of 22.32, a price-to-earnings-growth ratio of 2.39 and a beta of 1.20. The firm has a fifty day moving average price of $64.10 and a two-hundred day moving average price of $75.48.
Analysts Set New Price Targets
A number of equities research analysts have recently commented on BRKR shares. Citigroup reduced their price objective on shares of Bruker from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, July 10th. TD Cowen dropped their target price on shares of Bruker from $74.00 to $72.00 and set a “hold” rating on the stock in a research report on Wednesday, August 7th. Jefferies Financial Group started coverage on shares of Bruker in a research report on Monday, June 3rd. They set a “buy” rating and a $85.00 target price on the stock. Stifel Nicolaus dropped their target price on shares of Bruker from $81.00 to $77.00 and set a “hold” rating on the stock in a research report on Monday, May 20th. Finally, The Goldman Sachs Group dropped their target price on shares of Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a research report on Tuesday, July 9th. One research analyst has rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $80.80.
Get Our Latest Stock Report on Bruker
About Bruker
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
Featured Articles
- Five stocks we like better than Bruker
- How to Capture the Benefits of Dividend Increases
- Brinker International’s Price Dip is an Appetizing Entry Point
- Quiet Period Expirations Explained
- 3 Stocks That Could Beat the September Blues
- 3 Monster Growth Stocks to Buy Now
- Canopy Growth Stock: Can It Sustain Recent Gains?
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.